PharVision Advisers’s Fortrea Holdings FTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,792
Closed -$141K 800
2025
Q3
$141K Buy
+16,792
New +$129K 0.08% 579
2025
Q1
Sell
-18,487
Closed -$345K 357
2024
Q4
$345K Buy
+18,487
New +$360K 0.29% 111

Other funds holding FTRE

PharVision Advisers's FTRE Position: Q4 2025 in Review

PharVision Advisers sold out of Fortrea Holdings (FTRE) in Q4 2025, closing a stake of 16,792 shares — an estimated $141K sold.

PharVision Advisers first reported a position in FTRE in Q4 2024 and held it in 2 quarters. The position peaked at $345K in Q4 2024. 349 funds tracked by Wall St. Rank hold FTRE as of Q4 2025.

  • PharVision Advisers reported no remaining Fortrea Holdings position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 16,792 Fortrea Holdings shares in Q4 2025, an estimated $141K.
  • PharVision Advisers first reported a position in Fortrea Holdings in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Fortrea Holdings position peaked at $345K in Q4 2024.
  • 349 funds tracked by Wall St. Rank held Fortrea Holdings as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.